LHLabcorp
$366.64+46% 1Y
$366.64
$244.6952 weeks$368.11
Operating metrics
Biopharma Labs backlog at Labcorp: $8.92B for Q3 2026, +4.0% on a year ago.
Operating metrics
From earnings releases, Q2 2023 to Q3 2026
Biopharma Labs backlog, Q3 2026+4.0% on a year ago$8.92B
+4.0% on a year ago
Trailing twelve-month net orders$3.59B
Q3 2026, +7.5% on a year ago
Biopharma Labs backlog, Q3 2026: $8.92B
Backlog8.92(7)
Source: Q3 2026 earnings release, filed Oct 28, 2026Every quarter, with its source
| Quarter | Biopharma Labs backlog | Trailing twelve-month net orders | Release |
|---|---|---|---|
| Q3 2026 | $8.92B | $3.59B | Filed Oct 28, 2026 |
| Q2 2026 | $8.73B | $3.32B | Filed Jul 30, 2026 |
| Q1 2026 | $8.64B | $3.29B | Filed Apr 30, 2026 |
| Q4 2025 | $8.72B | $3.37B | Filed Feb 17, 2026 |
| Q3 2025 | $8.58B | $3.34B | Filed Oct 28, 2025 |
| Q2 2025 | $8.71B | $3.34B | Filed Jul 24, 2025 |
| Q1 2025 | $8.18B | $3.15B | Filed Apr 29, 2025 |
| Q4 2024 | $7.99B | $2.91B | Filed Feb 6, 2025 |
| Q3 2024 | $8.14B | $2.9B | Filed Oct 24, 2024 |
| Q2 2024 | $7.92B | $2.82B | Filed Aug 1, 2024 |
| Q1 2024 | $7.9B | $2.83B | Filed Apr 25, 2024 |
| Q4 2023 | $8.25B | $2.89B | Filed Feb 15, 2024 |
| Q3 2023 | $7.79B | $3.05B | Filed Oct 26, 2023 |
| Q2 2023 | $7.96B | $3.3B | Filed Jul 27, 2023 |
- Biopharma Labs backlog
- Backlog of the Biopharma Laboratory Services business at the end of the quarter, in USD (Drug Development backlog in earlier releases).
- Trailing twelve-month net orders
- Net orders of the Biopharma Laboratory Services business over the trailing twelve months, in USD.
Source: company earnings releases furnished to the SEC on Form 8-K (Item 2.02, Exhibit 99), SEC EDGAR.
Diagnostics & Research
The closest names by size in the same industry